Coagulation factor VIIa (3.4.21.21)

Industry

CPC
C12N9/6437

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N9/00Enzymes Proenzymes Compositions thereof Processes for preparing, activating, inhibiting, separating or purifying enzymes

Current Industry

C12N9/6437Coagulation factor VIIa (3.4.21.21)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Extended recombinant polypeptides and compositions comprising same
- Patent number 12,071,456
- Issue date Aug 27, 2024
- Amunix Pharmaceuticals, Inc.
- Volker Schellenberger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides that inhibit binding of EPCR to its ligand to treat inflam...
- Patent number 11,820,833
- Issue date Nov 21, 2023
- Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Nicola Maggio
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Means and methods for modifying multiple alleles
- Patent number 11,713,458
- Issue date Aug 1, 2023
- Octapharma AG
- Karina Nawrath
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acids encoding clotting factor variants and their use
- Patent number 11,633,504
- Issue date Apr 25, 2023
- Emory University
- Christopher Doering
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified polynucleotides for the production of cytoplasmic and cyto...
- Patent number 11,564,998
- Issue date Jan 31, 2023
- ModernaTX, Inc.
- Antonin De Fougerolles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein C-factor VII chimeras
- Patent number 11,560,556
- Issue date Jan 24, 2023
- Duke University
- Ammon Fager
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Short-acting Factor VII polypeptides
- Patent number 11,530,401
- Issue date Dec 20, 2022
- Coagulant Therapeutics Corporation
- Maxine Bauzon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,401,322
- Issue date Aug 2, 2022
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cell-associated secretion-enhancing fusion proteins
- Patent number 11,390,899
- Issue date Jul 19, 2022
- SOLA BIOSCIENCES, LLC
- Akinori Hishiya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Procoagulant compounds
- Patent number 11,261,437
- Issue date Mar 1, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong Hong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VII composition having a substantially homogenous isoelectri...
- Patent number 11,254,920
- Issue date Feb 22, 2022
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Guillaume Chevreux
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Factor VII polypeptides that are modified and uses thereof
- Patent number 11,203,749
- Issue date Dec 21, 2021
- Catalyst Biosciences, Inc.
- Edwin L. Madison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,168,125
- Issue date Nov 9, 2021
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric clotting factors
- Patent number 11,168,316
- Issue date Nov 9, 2021
- Bioverativ Therapeutics, Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on a...
- Patent number 11,135,275
- Issue date Oct 5, 2021
- Novo Nordisk Healthcare AG
- Ida Hilden
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunoglobulin chimeric monomer-dimer hybrids
- Patent number 11,084,866
- Issue date Aug 10, 2021
- Bioverativ Therapeutics Inc.
- Robert T. Peters
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Long-acting coagulation factors and methods of producing same
- Patent number 11,066,658
- Issue date Jul 20, 2021
- OPKO Biologics Ltd.
- Udi Eyal Fima
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Blood coagulation protein conjugates
- Patent number 11,040,109
- Issue date Jun 22, 2021
- Takeda Pharmaceutical Company Limited
- Juergen Siekmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric clotting factors
- Patent number 10,968,442
- Issue date Apr 6, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Long-acting coagulation factors and methods of producing same
- Patent number 10,960,058
- Issue date Mar 30, 2021
- OPKO Biologics Ltd.
- Udi Eyal Fima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Extended recombinant polypeptides and compositions comprising same
- Patent number 10,961,287
- Issue date Mar 30, 2021
- Amunix Pharmaceuticals, Inc.
- Volker Schellenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GLA domains as therapeutic agents
- Patent number 10,925,926
- Issue date Feb 23, 2021
- GLADIATOR BIOSCIENCES, INC.
- Maxine Bauzon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processable single chain molecules and polypeptides made using same
- Patent number 10,927,362
- Issue date Feb 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gla domains as targeting agents
- Patent number 10,894,075
- Issue date Jan 19, 2021
- GLADIATOR BIOSCIENCES, INC.
- Maxine Bauzon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Production of N-glycoproteins for enzyme assisted glycomodification
- Patent number 10,889,845
- Issue date Jan 12, 2021
- University of Copenhagen
- Shamim Herbert Rahman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GPIIB/IIIA antibodies and uses thereof
- Patent number 10,875,924
- Issue date Dec 29, 2020
- Biogen MA Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of controlling a polypeptide modification reaction
- Patent number 10,851,364
- Issue date Dec 1, 2020
- Novo Nordisk Healthcare AG
- Lars Sejergaard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Glycopolysialylation of non-blood coagulation proteins
- Patent number 10,772,968
- Issue date Sep 15, 2020
- Lipoxen Technologies Limited
- Sanjay Jain
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Grant
Modified Polynucleotides for the production of biologics and protei...
- Patent number 10,772,975
- Issue date Sep 15, 2020
- ModernaTX, Inc.
- Stephane Bancel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tissue factor (TF)—targeted nanotherapy
- Patent number 10,738,294
- Issue date Aug 11, 2020
- Melina R. Kibbe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTO...
- Publication number 20240131193
- Publication date Apr 25, 2024
- Modema TX, Inc.
- Antonin DE FOUGEROLLES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES
- Publication number 20240002841
- Publication date Jan 4, 2024
- Octapharma AG
- Karina Nawrath
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTER-APPLICATION WORKFLOW PERFORMANCE ANALYTICS
- Publication number 20230374095
- Publication date Nov 23, 2023
- BOX, INC.
- Rohit Bakshi
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES
- Publication number 20230374501
- Publication date Nov 23, 2023
- Octapharma AG
- Karina Nawrath
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SHORT-ACTING FACTOR VII POLYPEPTIDES
- Publication number 20230295596
- Publication date Sep 21, 2023
- Coagulant Therapeutics Corporation
- Maxine Bauzon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEIN...
- Publication number 20230287471
- Publication date Sep 14, 2023
- APTEVO BIOTHERAPEUTICS LLC
- William N. Drohan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS, DEVICES, AND METHODS FOR FACTOR VII THERAPY
- Publication number 20230123802
- Publication date Apr 20, 2023
- SIGILON THERAPEUTICS, INC.
- Lauren Emily Barney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
- Publication number 20230023927
- Publication date Jan 26, 2023
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED CELLS FOR CONTROLLED PRODUCTION
- Publication number 20220411795
- Publication date Dec 29, 2022
- William Marsh Rice University
- Omid VEISEH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCOAGULANT COMPOUNDS
- Publication number 20220243189
- Publication date Aug 4, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong HONG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF
- Publication number 20220213200
- Publication date Jul 7, 2022
- Biogen MA Inc.
- Joe Salas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME
- Publication number 20220170005
- Publication date Jun 2, 2022
- OPKO Biologics Ltd.
- Udi Eyal FIMA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20220135959
- Publication date May 5, 2022
- Bioverativ Therapeutics Inc.
- Joe SALAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES
- Publication number 20220089745
- Publication date Mar 24, 2022
- Biogen MA Inc.
- Bradley Pearse
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN COAGULATION FACTOR VII POLYPEPTIDES
- Publication number 20220073895
- Publication date Mar 10, 2022
- Novo Nordisk Healthcare AG
- Henrik Oestergaard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Virus Filtration of Liquid Factor VII Compositions
- Publication number 20220064605
- Publication date Mar 3, 2022
- Novo Nordisk Healthcare AG
- Jesper Christensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
- Publication number 20220010000
- Publication date Jan 13, 2022
- Bioverativ Therapeutics Inc.
- Robert T. PETERS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME
- Publication number 20220000990
- Publication date Jan 6, 2022
- OPKO Biologics Ltd.
- Udi Eyal FIMA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES
- Publication number 20210371487
- Publication date Dec 2, 2021
- OPKO Biologics Ltd.
- Oren HERSHKOVITZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20210355473
- Publication date Nov 18, 2021
- Bioverativ Therapeutics Inc.
- Joe SALAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA
- Publication number 20210348150
- Publication date Nov 11, 2021
- Bioverativ Therapeutics Inc.
- Daniel S. Rivera
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEI...
- Publication number 20210299278
- Publication date Sep 30, 2021
- ModernaTX, Inc.
- Stephane BANCEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Protein C-Factor VII Chimeras
- Publication number 20210301277
- Publication date Sep 30, 2021
- Ammon FAGER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME
- Publication number 20210292729
- Publication date Sep 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IN VIVO POST-TRANSLATIONAL PROCESSING OF TARGET PROTEIN BY FURIN IN...
- Publication number 20210292730
- Publication date Sep 23, 2021
- Akdeniz Universitesi
- Tarlan MAMMEDOV
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING...
- Publication number 20210277378
- Publication date Sep 9, 2021
- Bioverativ Therapeutics Inc.
- Volker SCHELLENBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME
- Publication number 20210277074
- Publication date Sep 9, 2021
- Amunix Pharmaceuticals
- Volker Schellenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-GPIIB/IIIA ANTIBODIES AND USES THEREOF
- Publication number 20210246212
- Publication date Aug 12, 2021
- Biogen MA Inc.
- Joe Salas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLA DOMAINS AS TARGETING AGENTS
- Publication number 20210113657
- Publication date Apr 22, 2021
- GLADIATOR BIOSCIENCES, INC.
- Maxine BAUZON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEIN...
- Publication number 20210095323
- Publication date Apr 1, 2021
- APTEVO BIOTHERAPEUTICS LLC
- William N. Drohan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Coagulation factor VIIa (3.4.21.21)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Extended recombinant polypeptides and compositions comprising same

Peptides that inhibit binding of EPCR to its ligand to treat inflam...

Means and methods for modifying multiple alleles

Nucleic acids encoding clotting factor variants and their use

Modified polynucleotides for the production of cytoplasmic and cyto...

Protein C-factor VII chimeras

Short-acting Factor VII polypeptides

Immunoglobulin chimeric monomer-dimer hybrids

Cell-associated secretion-enhancing fusion proteins

Procoagulant compounds

Factor VII composition having a substantially homogenous isoelectri...

Factor VII polypeptides that are modified and uses thereof

Immunoglobulin chimeric monomer-dimer hybrids

Chimeric clotting factors

Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on a...

Immunoglobulin chimeric monomer-dimer hybrids

Long-acting coagulation factors and methods of producing same

Blood coagulation protein conjugates

Chimeric clotting factors

Long-acting coagulation factors and methods of producing same

Extended recombinant polypeptides and compositions comprising same

GLA domains as therapeutic agents

Processable single chain molecules and polypeptides made using same

Gla domains as targeting agents

Production of N-glycoproteins for enzyme assisted glycomodification

Anti-GPIIB/IIIA antibodies and uses thereof

Method of controlling a polypeptide modification reaction

Glycopolysialylation of non-blood coagulation proteins

Modified Polynucleotides for the production of biologics and protei...

Tissue factor (TF)—targeted nanotherapy

Patents Applicationslast 30 patents

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTO...

MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES

INTER-APPLICATION WORKFLOW PERFORMANCE ANALYTICS

MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES

SHORT-ACTING FACTOR VII POLYPEPTIDES

METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEIN...

COMPOSITIONS, DEVICES, AND METHODS FOR FACTOR VII THERAPY

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

ENGINEERED CELLS FOR CONTROLLED PRODUCTION

PROCOAGULANT COMPOUNDS

ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF

LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME

CHIMERIC CLOTTING FACTORS

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

HUMAN COAGULATION FACTOR VII POLYPEPTIDES

Virus Filtration of Liquid Factor VII Compositions

IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS

LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME

METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES

CHIMERIC CLOTTING FACTORS

CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEI...

Protein C-Factor VII Chimeras

PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME

IN VIVO POST-TRANSLATIONAL PROCESSING OF TARGET PROTEIN BY FURIN IN...

COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING...

EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME

ANTI-GPIIB/IIIA ANTIBODIES AND USES THEREOF

GLA DOMAINS AS TARGETING AGENTS

METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEIN...